About: Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 1996

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 1996 (uk) article scientifique publié en 1996 (fr) im Februar 1996 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en febreru de 1996 (ast) artikull shkencor i botuar më 01 shkurt 1996 (sq) scientific article published on 01 February 1996 (en)
publication date	wds:Q70901893-A64A93AA-DC1B-4A53-A8B9-56A57B226033
publication date	1996-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q70901893-34F91D84-102E-4A88-97A4-C667E7339D5C
language of work or name	English
exact match	wds:Q70901893-A5BB50E5-63A3-473C-9E3A-84E5DE47F381
exact match	https://scigraph.springernature.com/pub.10.1038/bjc.1996.71
cites work	wds:Q70901893-09E2C628-2EC3-473A-86AE-27847E12CD3F wds:Q70901893-13E34967-54F4-43E1-AB7C-6EBC97C51CD5 wds:Q70901893-2BD2219C-017A-4813-A280-8C70616F71C1 wds:Q70901893-3E42D0D6-8432-4155-9681-6130C00B059B wds:Q70901893-4B55EB6D-E8AF-4384-88DE-9B484B365613 wds:Q70901893-51974996-3D93-488F-94DE-980D21E88EF6 wds:Q70901893-5B69781E-0B82-4DE4-8B89-D04907CAB3DD wds:Q70901893-69676B03-FB9B-4ED2-BE69-E6E2360C20D3 wds:Q70901893-7DBE595F-4A37-40AE-A996-9D062D2D58D8 wds:Q70901893-90DA5304-DD61-4E2E-9B34-8AAAC011F2AE wds:Q70901893-997358E8-8731-445D-BEA8-B076A557B863 wds:Q70901893-AB73DB87-C542-4394-A533-1BE9143BF6FE wds:Q70901893-CC169571-F941-40A3-9EA3-F0B8FCA5B590 wds:Q70901893-D7F0DC8F-0A5E-48CB-A60B-A26DA2691834
cites work	A randomised trial of planned versus as required chemotherapy in small cell lung cancer: a Cancer Research Campaign trial The hospital anxiety and depression scale Approaches to the analysis of quality of life data: experiences gained from a medical research council lung cancer working party palliative chemotherapy trial Assessment of quality of life in small-cell lung cancer using a Daily Diary Card developed by the Medical Research Council Lung Cancer Working Party Who should measure quality of life, the doctor or the patient? Patients at risk of chemotherapy-associated toxicity in small cell lung cancer Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Medical Research Council Lung Cancer Working Party Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party Management of small-cell cancer of the lung Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index--Cancer Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer Stress buffering effect of psychological support in a diabetic camp
rdfs:label	Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (nl) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (en) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (sq)
skos:prefLabel	Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (nl) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (en) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (sq)
name	Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (nl) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (en) Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (sq)
title	wds:Q70901893-14C310C2-2047-49CE-98EF-88CC0C097C11
title	Randomised trial of four-drug vs less intensive two-drug chemotherapy in the palliative treatment of patients with small-cell lung cancer (SCLC) and poor prognosis. Medical Research Council Lung Cancer Working Party (en)
page(s)	wds:Q70901893-1DC47252-C334-4D9A-9C3D-2AE26304F095
page(s)	406-413
instance of	wds:Q70901893-3DD3B78B-1897-4403-8FF1-C1D8AF11715A
instance of	scholarly article
main subject	wds:Q70901893-AAD5B496-CE5D-48EE-8F54-604E9D591C44 wds:Q70901893-B9F5D327-58AE-4415-9B7D-F7D4693121C7
main subject	lung cancer chemotherapy
PubMed ID	wds:Q70901893-38F86C1C-6D4B-4DD0-B076-31AF4A20FFA1
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8562352
PubMed ID	8562352
published in	wds:Q70901893-5D2790A2-38D4-4E55-839B-85355111CBF2
published in	British Journal of Cancer
issue	wds:Q70901893-DE928906-7729-49F6-89AF-74A20418F029
volume	wds:Q70901893-F5742C86-30B7-4C7F-8DFD-14C58FEFBAB6
issue	3
volume	73
DOI	wds:Q70901893-13D0C83E-6EBE-4B85-B787-260E16906868
DOI	http://dx.doi.org/10.1038/BJC.1996.71
DOI	10.1038/BJC.1996.71
PMCID	wds:Q70901893-5D582F43-D62D-4124-A0FD-02CB4EF12041
PMCID	2074416
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q70901893
is cites work of	Assessment and treatment of depression in the cancer patient. Interventions for preventing oral mucositis for patients with cancer receiving treatment Chemotherapy versus best supportive care for extensive small cell lung cancer Sample sizes for randomized trials measuring quality of life in cancer patients. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer Interventions for preventing oral mucositis for patients with cancer receiving treatment Interventions for preventing oral mucositis for patients with cancer receiving treatment Chemotherapy versus best supportive care for extensive small cell lung cancer Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial. Medical Research Council Lung Cancer Working Party. Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses Interventions for preventing oral mucositis for patients with cancer receiving treatment Early death during chemotherapy in patients with small-cell lung cancer: derivation of a prognostic index for toxic death and progression Randomized phase II study of cyclophosphamide, doxorubicin, and vincristine compared with single-agent carboplatin in patients with poor prognosis small cell lung carcinoma Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials Predictive and prognostic factors in small cell lung cancer: current status. Survey of the Administration of quality of life (QL) questionnaires in three multicentre randomised trials in cancer. The Medical Research Council Lung Cancer Working Party the CHART Steering Committee. The analysis, interpretation, and presentation of quality of life data Defining and analysing symptom palliation in cancer clinical trials: a deceptively difficult exercise Chemotherapy versus best supportive care for extensive small cell lung cancer What has been learned from measuring health-related quality of life in clinical oncology. Modern management of small-cell lung cancer Treatment of lung cancer in elderly part II: small cell lung cancer

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software